Physician

Daniel Robert Salisbury, M.D.

According to 2025 Medicare claims, Daniel Salisbury, M.D. (NPI: 1801280995) practices ophthalmology in the Alexandria, LA market, with the plurality of this provider's patient population coming from Rapides, LA. This provider's primary affiliated billing organization is VITREORETINAL INSTITUTE, A MEDICAL CORPORATION (NPI: 1649226580; TIN: 721037444) and primary practice location at 71301-8423.

Salisbury's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 538 traditional Medicare patients, billed 6,090 HCPCS/CPT codes, and received $395,671 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 375 prescription claims across 138 beneficiaries totaling $18,444 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 29 records totaling $910. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $10,120 to $395,671. Similarly, Part D prescription costs have risen steadily, from $1,324 to $18,444. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$198K$396K2019 Medicare payment: $10,120 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $15,706 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $37,322 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $117,270 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $242,423 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $395,671 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20196583$10,120
2020105138$15,706
202194279$37,322
20221171,070$117,270
20232243,656$242,423
20245386,090$395,671

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.2K$18K2015 Drug cost: $1,324 (USD; Tot_Drug_Cst)2016 Drug cost: $1,822 (USD; Tot_Drug_Cst)2017 Drug cost: $3,912 (USD; Tot_Drug_Cst)2018 Drug cost: $290 (USD; Tot_Drug_Cst)2019 Drug cost: $10,340 (USD; Tot_Drug_Cst)2020 Drug cost: $10,214 (USD; Tot_Drug_Cst)2021 Drug cost: $5,169 (USD; Tot_Drug_Cst)2022 Drug cost: $4,002 (USD; Tot_Drug_Cst)2023 Drug cost: $15,733 (USD; Tot_Drug_Cst)2024 Drug cost: $18,444 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151434$1,324
20162249$1,822
201726109$3,912
2018N/R23$290
20193163$10,340
202054141$10,214
20212957$5,169
20223393$4,002
202383219$15,733
2024138375$18,444

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more108108$129
67028Injection of drug into eye89213$89
92014Established patient complete exam of visual system419560$89
92134Imaging of retina448680$29
92250Photography of the retina5253$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate844,309$4,887
Bromfenac SodiumBromfenac Sodium12345$1,600
Ketorolac TromethamineKetorolac Tromethamine392,021$1,421
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat564,390$651
LatanoprostLatanoprost563,052$646

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$910Mallinckrodt Hospital Products Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel Robert Salisbury, M.D.?

Tedicare shows public-source Medicare data for Daniel Robert Salisbury, M.D. (NPI 1801280995), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Robert Salisbury, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Robert Salisbury, M.D.?

Daniel Robert Salisbury, M.D. is linked to VITREORETINAL INSTITUTE, A MEDICAL CORPORATION (billing NPI 1649226580) in the available physician profile data.

Does Daniel Robert Salisbury, M.D. have Open Payments data?

Daniel Robert Salisbury, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.